A clinical trial to study the efficacy of aromatase inhibitors as an ovulation inducing drug in clomiphene resistant cases.

Aromatase inhibitors in clomiphene resistant women:A randomised double blind placebo controlled trial.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2007/091/000048

Enrollment

Registered

2008-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: letrozole(aromatase inhibitor): 2.5mgs , Day2- Day6 Control Intervention1: placebo: 2.5mgs from day2-day6

Eligibility

Inclusion criteria

Inclusion criteria: 1.Anovulatory women with clomiphene resistance 2.Normal male factor 3.Normal hormonal profile-FSH/TSH/Prolactin 4.Women available for follow up

Exclusion criteria

Exclusion criteria: 1.Ovulatory cycle 2.Abnormal semen analysis

Design outcomes

Primary

Measure	Time frame
OvulationTimepoint: 12months	—

Secondary

Measure	Time frame
1.Clinical pregnancy 2.Endometrial thickness 3.Trilaminar patternTimepoint: 12months;live birthsTimepoint: 12months	—

Countries

India

Contacts

Public ContactDr Mohan S Kamath

rmu@cmcvellore.ac.in9104162283301

Outcome results